ALNY

Neutral

Assessing Alnylam Pharmaceuticals (ALNY) Valuation After Mixed Share Performance And Strong AMVUTTRA Uptake

Alnylam Pharmaceuticals (ALNY) has seen mixed share performance recently, but its new drug AMVUTTRA is experiencing strong uptake, leading to a narrat...

Simply Wall Street 2 weeks ago 0

Neutral

Capstone Capital Management Ltd Acquires Shares of 2,301 Alnylam Pharmaceuticals, Inc. $ALNY

Capstone Capital Management Ltd purchased a new stake in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) in the fourth quarter, Holdings Cha...

thelincolnianonline 3 weeks ago 0